Results · Apr-Jun 2026
Medi-Caps Q1 FY27 results
Sales grew 4% to ₹2.8 crore from ₹2.7 crore in Apr-Jun 2025.
Operating profit was −₹1.8 crore, an operating margin of −65.7% (up 59.9 points from a year ago).
The net loss narrowed to ₹2.2 crore from ₹3.5 crore.
Against Jan-Mar 2026: sales −19%, swings to a loss.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 2.8 | 2.7 | +4% |
| Operating profit (EBITDA) | -1.8 | -3.4 | n/m |
| Operating margin | −65.7% | −125.7% | +59.9 pts |
| Net profit | -2.2 | -3.5 | loss narrows |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.